The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Jeffrey W. Dunn, insider at SI-BONE

Jeffrey W. Dunn Insider Information

Director of SI-BONE
Jeffrey W. Dunn serves as the Executive Chairman to our Board of Directors.  Mr. Dunn previously served as the President, Chief Executive Officer and Chairman of our Board of Directors from our inception in April 2008 until April 2021. Prior to joining SI BONE, Mr. Dunn served as Chief Executive Officer of INBONE Technologies, Inc., an ankle replacement and small bone fusion medical device company, from December 2006 to April 2008, until its sale to Wright Medical Technology, Inc. in April 2008. From August 2000 to June 2006, Mr. Dunn was the Chief Executive Officer of Active Decisions, Inc., a software as a service business, until its sale to Knova Software, Inc. From December 1999 to June 2000, Mr. Dunn was the Chief Executive Officer of Velogic, Inc., an internet performance testing software company, until its sale to Keynote Systems Inc. From June 1999 to December 1999, Mr. Dunn was the Chief Executive Officer of EnterpriseLink Inc., a provider of enterprise Internet enablement software, until its sale to Merant, Inc. From November 1994 to June 1998, Mr. Dunn was Chief Executive Officer of AccelGraphics Inc., a 3D graphics system supplier, until its sale to Evans and Sutherland Computer Corporation. Mr. Dunn has started numerous companies, taken two public and all the other companies he headed as CEO were acquired by larger public companies. As well, during his career, Mr. Dunn held executive positions with Evans and Sutherland, Cygnet Systems, Inc., Avnet, Inc. and Xerox Corporation. Mr. Dunn received a B.A. from Colgate University and an M.B.A. from Babson College.

What is Jeffrey W. Dunn's net worth?

The estimated net worth of Jeffrey W. Dunn is at least $1.87 million as of May 16th, 2022. Mr. Dunn owns 137,383 shares of SI-BONE stock worth more than $1,868,409 as of July 3rd. This net worth estimate does not reflect any other investments that Mr. Dunn may own. Learn More about Jeffrey W. Dunn's net worth.

What is Jeffrey W. Dunn's salary?

As the Director of SI-BONE, Inc., Mr. Dunn earned a total compensation package of $4,240,493.00 in 2020. Mr. Dunn earned a salary of $555,000.00, stock awards of $3,119,260.00, non-equity compensation of $544,199.00, and other compensation of $22,034.00. Learn More on Jeffrey W. Dunn's salary.

How do I contact Jeffrey W. Dunn?

The corporate mailing address for Mr. Dunn and other SI-BONE executives is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. SI-BONE can also be reached via phone at (408) 207-0700 and via email at [email protected] Learn More on Jeffrey W. Dunn's contact information.

Has Jeffrey W. Dunn been buying or selling shares of SI-BONE?

Jeffrey W. Dunn has not been actively trading shares of SI-BONE over the course of the past ninety days. Learn More on Jeffrey W. Dunn's trading history.

Who are SI-BONE's active insiders?

SI-BONE's insider roster includes Jeffrey Dunn (Director), Laura Francis (CEO), John Freund (Director), Jeryl Hilleman (Director), Gregory Hinckley (Director), Michael Pisetsky (SVP), and Anthony Recupero (Insider). Learn More on SI-BONE's active insiders.

Are insiders buying or selling shares of SI-BONE?

In the last year, insiders at the sold shares 30 times. They sold a total of 83,206 shares worth more than $1,555,740.96. The most recent insider tranaction occured on June, 13th when Director Jeryl L Hilleman sold 1,924 shares worth more than $26,570.44. Insiders at SI-BONE own 5.4 % of the company. Learn More about insider trades at SI-BONE.

Information on this page was last updated on 6/13/2022.

Jeffrey W. Dunn Insider Trading History at SI-BONE

See Full Table

Jeffrey W. Dunn Buying and Selling Activity at SI-BONE

This chart shows Jeffrey W. Dunn's buying and selling at SI-BONE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SI-BONE Company Overview

SI-BONE logo
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $13.60
Low: $12.87
High: $13.70

50 Day Range

MA: $15.02
Low: $12.05
High: $21.03

2 Week Range

Now: $13.60
Low: $11.89
High: $32.13

Volume

134,453 shs

Average Volume

212,415 shs

Market Capitalization

$460.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.